Pricing Log in Create free account
Saturday 10 October 2026 Export all NVO data to Excel Powerpack

Novo Nordisk A/S

NVO Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024. In the quarter to June 2026, revenue grew 4.47%, EPS fell 18.7%, free cash flow grew 71.6% and total debt rose 44.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for five.

38.64 0.46 +1.20%
Market cap
$127.8B
P/E
9.4×
Fwd P/E
—
Dividend yield
4.65%
F-score
5/9
Altman Z
4.32
Beneish M
−2.51
Dividend safety
46/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Novo Nordisk A/S (NVO) P/E ratio

Alert me on P/E ratio

As of 9 October 2026, Novo Nordisk A/S (NVO) trades at a P/E ratio of 9.4×. Over the past ten years it has ranged from 8.6× (April 2026) to 50.7× (June 2024); the current reading is higher than 1% of that period. That is below the Drug Manufacturers General industry median of 23.6× and below the Healthcare sector median of 22.5×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 14.7× (43.92%)
FY2024 26.1× (30.74%)
FY2023 37.7× (4.36%)
FY2022 39.5× 16.65%
FY2021 33.8× 33.20%
FY2020 25.4× 7.97%
FY2019 23.5× 29.18%
FY2018 18.2× (21.64%)
FY2017 23.2× 44.31%
FY2016 16.1× (44.26%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 11.7× 35.87%
Mar 2026 8.6× (41.17%)
Dec 2025 14.7× (9.10%)
Sep 2025 16.1× (14.93%)
42 more quarters

Against its own ten years

Low 8.6× High 50.7×
Ten-year median 25.5×
Current reading's percentile 1

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S 9.4×
BMY Bristol Myers Squibb Company compare 13.0×
GSK GSK PLC Sponsored ADR compare 14.5×
SNY Sanofi compare 21.0×
NVS Novartis AG compare 21.6×
AZN AstraZeneca PLC compare 23.6×
AMGN Amgen Inc. compare 25.6×
PFE Pfizer Inc. compare 37.2×
Drug Manufacturers General industry median 23.6×
Healthcare sector median 22.5×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on NVO